Maintenance Treatment of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease on Darbepoetin Treatment Versus BAY85-3934
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 126 participants.
Also called NCT02021409
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 126 participants
- Sponsor
- Registry
-
NCT02021409 -
2013-001192-21
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Australia, Bulgaria, France, Germany, Hungary, Israel, Italy, Japan, Poland, Romania, South Korea, Spain, Türkiye, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02021409. Randomized; no masking; primary purpose treatment. Start 2014-01-28 (actual); primary completion 2015-10-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Maintenance Treatment of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease on Darbepoetin Treatment Versus BAY85-3934
- Acronym
- DIALOGUE 2
- Condition
- Anemia
- Condition
- Renal Insufficiency, Chronic
- Intervention (Drug)
- BAY85-3934
- Intervention (Biological)
- Darbepoetin alfa
- Lead sponsor
- Bayer
Record details
- Record id
cardio:ct-nct02021409- Content hash
2bcb7ffa3da73175f0643583615d6c09a90880db39271d6adcee244bc0b7211f